Koninklijke Philips N.V. (PHIA)

Basic

  • Market Cap

    €17.02B

  • EV

    €22.87B

  • Shares Out

    906.4M

  • Revenue

    €18.17B

  • Employees

    69,656

Margins

  • Gross

    40.99%

  • EBITDA

    6.2%

  • Operating

    2.3%

  • Pre-Tax

    -2.9%

  • Net

    -2.56%

  • FCF

    10.53%

Returns (5Yr Avg)

  • ROA

    1.94%

  • ROTA

    7.33%

  • ROE

    5.8%

  • ROCE

    4.27%

  • ROIC

    3.46%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €20.59

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €1,872M

  • Net Debt

    €5,817M

  • Debt/Equity

    0.64

  • EBIT/Interest

    1.46

Growth (CAGR)

  • Rev 3Yr

    1.62%

  • Rev 5Yr

    0.05%

  • Rev 10Yr

    -1.89%

  • Dil EPS 3Yr

    -21.5%

  • Dil EPS 5Yr

    -17.54%

  • Dil EPS 10Yr

    -7.16%

  • Rev Fwd 2Yr

    4.36%

  • EBITDA Fwd 2Yr

    10.27%

  • EPS Fwd 2Yr

    16.59%

  • EPS LT Growth Est

    16.15%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    2.69%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Total Revenues

17,147

17,313

17,156

17,827

18,169

Total Revenues % Chg.

-5.4%

1%

-0.9%

3.9%

1.9%

Cost of Goods Sold, Total

9,199

9,401

9,988

10,633

10,721

Gross Profit

7,948

7,912

7,168

7,194

7,448

Selling General & Admin Expenses, Total

4,582

4,564

4,865

5,302

5,153

R&D Expenses

1,639

1,691

1,806

1,957

1,890

Other Operating Expenses

7

-28

-16

20

-12

Other Operating Expenses, Total

6,228

6,227

6,655

7,279

7,031

Operating Income

1,720

1,685

513

-85

417

Interest Expense, Total

-173

-169

-156

-234

-285

Interest And Investment Income

77

16

20

28

48

Net Interest Expenses

-96

-153

-136

-206

-237

Income (Loss) On Equity Invest.

1

-9

-4

-2

-98

Currency Exchange Gains (Loss)

-2

4

9

-23

Other Non Operating Income (Expenses)

-18

-10

9

-3

-7

EBT, Excl. Unusual Items

1,605

1,517

382

-287

52

Restructuring Charges

-134

Impairment of Goodwill

-97

-144

-15

-1,357

-8

Gain (Loss) On Sale Of Investments

19

129

95

9

-26

Gain (Loss) On Sale Of Assets

72

2

-57

6

61

Asset Writedown

-50

-92

Legal Settlements

-38

17

-60

-606

Other Unusual Items

-302

-163

87

92

EBT, Incl. Unusual Items

1,247

1,211

509

-1,731

-527

Income Tax Expense

258

212

-103

-113

-73

Earnings From Continuing Operations

989

999

612

-1,618

-454

Earnings Of Discontinued Operations

183

196

2,711

13

-10

Minority Interest

-5

-8

-4

-3

-2

Net Income

1,167

1,187

3,319

-1,608

-466

Net Income to Common Incl Extra Items

1,167

1,187

3,319

-1,608

-466

Net Income to Common Excl. Extra Items

984

991

608

-1,621

-456

Total Shares Outstanding

949.6

945.6

909

920.8

906.4

Weighted Avg. Shares Outstanding

962.2

948.3

943.6

921

917.4

Weighted Avg. Shares Outstanding Dil

972.3

957.6

949

921

917.4

EPS

1.2

1.3

3.5

-1.7

-0.5

EPS Diluted

1.2

1.2

3.5

-1.7

-0.5

EBITDA

2,624

2,752

1,464

669

1,127